Sigumir
Cartilage & Bone Extract Bioregulator · Musculoskeletal Cytomax · Сигумир
Sigumir is the Cytomax cartilage/joint/spine complex. Cartalax (Ala-Glu-Asp) is the chondrocyte cytogen. This is not BPC-157, not a viscosupplement, and not a collagen powder.
Quick answer
What it is: Sigumir is the Cytomax cartilage/joint/spine complex.
Class and target: Cytomax (natural peptide complex) · Joints, cartilage, and spine
Typical research dose: 1-2 capsules/day
Dosing details ↓What it is & the evidence on The Bioregulator Atlas →
Research summary, not medical advice.
Use-case scores
- Longevity / aging3.5/10
- Injury & tissue3/10
Compound card
- Sequence
- Joints, cartilage, and spine peptide complex (mixture, not a single CAS)
- Class
- Khavinson Cytomax capsule complex (Joints, cartilage, and spine)
- Formula
- Polypeptide extract (Cartilage & Bone tissue <10 kDa)
- Status
- Not FDA-approved · research use
How it works
Sigumir (A-4) is a Cytomax natural polypeptide extract from the cartilage and bone tissue of young calves, targeting human chondrocytes, osteoblasts, and synovial cells to restore the gene expression governing collagen matrix synthesis, proteoglycan production, and anti-inflammatory joint signaling. Osteoarthritis affects approximately 250 million people globally and is fundamentally a disease of cartilage degradation: chondrocytes (cartilage cells) progressively lose their ability to synthesize type II collagen and aggrecan (the proteoglycan that gives cartilage its compressive strength), while simultaneously upregulating matrix metalloproteinases (MMP-13, ADAMTS-5) that degrade the extracellular matrix.
Sigumir delivers short peptide signals (<10 kDa) from bovine cartilage and bone tissue. These peptides enter chondrocyte and osteoblast nuclei to reactivate age-silenced genes encoding: type II collagen (COL2A1), aggrecan (ACAN), SOX9 (the master transcription factor for chondrocyte differentiation), and anti-inflammatory cytokines (IL-1Ra, which directly blocks the cartilage-destructive IL-1β signaling). Unlike glucosamine/chondroitin supplementation (which provides building block substrates), Sigumir works at the transcription level - it tells chondrocytes to re-express the genes for building these molecules.
In Khavinson's protocol, Sigumir (A-4, cartilage/bone) is combined with Gotratix (A-18, skeletal muscle) and Bonomarlot (A-20, bone marrow) to create the complete locomotor system protocol addressing cartilage, muscle, and blood cell regeneration simultaneously.
Source: PMID: 11713572
Khavinson map
Canonical 41Used in bioregulator stacks
Manufacturer-style organ combinations - not FDA protocols. Every name is a live leaf.
The Khavinson school
Sigumir is filed here as cytomax (natural peptide complex), targeting the joints, cartilage, and spine. Khavinson's St. Petersburg group moved from organ extracts (Cytamins) to capsule complexes (Cytomaxes) to synthetic short peptides (Cytogens); most of the evidence comes from that one group, with little independent Western replication.
Read the full background, the proposed epigenetic mechanism, the literature limits, and how we count the canonical 41 on the Khavinson bioregulators index.
History of this molecule
Degenerative joint disease is where peptide vendors all show up with a different story. BPC-157 is a gastric fragment with wound-healing animal data. TB-500 is actin. Khavinson’s play is chondrocyte gene expression - proteoglycan and collagen-II transcription in aging cartilage. Sigumir is the complex; Cartalax is the tripeptide.
Spine in the marketing line means vertebral joints and disc-adjacent tissue in the extract logic, not “inject this into L5.” Oral complex. Not an epidural.
Caveats
Joint Cytomax is not a US dietary-supplement monograph and not a drug. The tissue-extract model means lot-to-lot composition is a fingerprint, not a single CAS number. Some English-language bottles carry a “V2” label. Vita Peptides, for example, labels its own house line V2 (15 mg per capsule vs 10 mg in V1). No study compares V1 and V2 outcomes, and neither label is the subject of Khavinson’s 1990s papers. Animal-source capsules are inappropriate if the reader has a religious or allergy constraint on the source species. None of this replaces care for the actual organ disease.
Full 41-map: Khavinson bioregulators index · Bioregulator stacks
Research Use Cases
- ✓Musculoskeletal Cytomax vs Cartalax
- ✓Not osteoarthritis or osteoporosis treatment
Dosing
| Phase | Dose | Frequency | Notes |
|---|---|---|---|
| Mini-Course / General Preventive (1 box) | 2 capsules (20 mg) | Once daily for 10 days, 30 min before meals | Standard Khavinson mini-course (20 caps). Repeat every 6 months. Best combined with Gotratix (A-18, muscle) for the complete joint-muscle unit support. |
| Full Monthly Course (Joint Pain / OA) | 2 capsules (20 mg) | Twice daily for 30 days (120 caps = 2× 60-cap boxes) | Bi-annual 30-day courses for adults with osteoarthritis, joint pain, or significant cartilage loss. Core locomotor stack: Sigumir (A-4) + Gotratix (A-18) + Bonomarlot (A-20) per Khavinson locomotor system protocol. |
| Intensive / Joint Restoration Protocol | 2 capsules (20 mg) | Twice daily, repeated monthly as needed | For advanced osteoarthritis, post-operative joint recovery, or significant cartilage loss confirmed on imaging. Physician supervision advised. Max: 4 caps/day (40 mg). |
Administration
Sigumir: Not a research vial vs Oral capsule
- The defined-sequence vial in this aisle is the cytogen pair (Cartalax (AED)), a different SKU.
- There is no pharmaceutical-extract SKU that is this capsule in a syringe.
- Reconstitute Cartalax if you bought the AED vial. Intra-articular “Sigumir shots” are not a Cytomed protocol. This is not BPC-157.
- Sigumir is an oral capsule complex. It is not a 5 mg lyophilized research vial.
- Inventing recon math for a zero-mg Cytomax vial is how people inject the wrong product.
- Not an official Cytomed sublingual tablet, IM ampoule, or eye drop either.
- Official form for Sigumir: swallow the capsule with water. No reconstitution step and no 5 mg cake.
- Joint Cytomax (Cytomed A-4): chondrocyte aisle. Oral complex, not an epidural and not a viscosupplement. Gotratix is muscle.
- Course-based (10–30 days, a few times a year in manufacturer folklore), not a daily forever drug.
- Cartilage / joint / spine Cytomax is a peptide mixture / lot fingerprint, not a single CAS. English “V2” bottles are a later commercial layer, not a Khavinson RCT.
- Russian school literature is not an FDA organ-disease label.
- Third-party lingual SKUs exist in the wild. We do not claim sublingual as the official Cytomed Cytomax form.
Timeline
Who it is for
Osteoarthritis / Joint Health (Ages 45+)
LowRestores chondrocyte and osteoblast gene expression at the transcription level rather than just providing building block supplements like glucosamine.
Athletic Joint Preservation
LowFor high-load athletes seeking to slow cartilage wear. Best combined with Gotratix for complete joint-muscle support.
Safety & Considerations
Natural glandular extract (Cytomax) from bovine cartilage and bone tissue, <10 kDa. No hormones. Meets European/Russian veterinary standards. Generally recognized as safe.
Regulatory & Legal Status
Not currently on the WADA 2026 Prohibited List. Policies may change - verify before competition.
Research Chemical
US Compounding: Not eligible / not available
⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.
Limits of current evidence
- Cytomax SKUs are oral capsules. Do not run SubQ reconstitution math on a zero-mg vial.
- Lot-to-lot composition is a fingerprint, not one sequence.
- This site will not treat the named organ disease from a peptide page.
- English-language V2 / analog bottles are a later commercial layer, not a Khavinson RCT.
Verdict
Sigumir is a Cytomax capsule complex from Joints, cartilage, and spine. It is not the paired cytogen, not a 5 mg research cake, and not a US supplement monograph. The organ story is in the dossier on this page.
Interactions & Contraindications
This site will not treat joint disease from a peptide page.
Synergies & Common Stacks
Complex vs tripeptide.
Appears in goal guides
Goal guides are maps, not clinic protocols. A mention here is not a treatment plan.
Frequently Asked Questions
Oral capsule or injection?▼
Sigumir vs Cartalax vs BPC-157?▼
Injections into the joint?▼
Pair with Gotratix?▼
Reconstitution?▼
How is Sigumir different from glucosamine/chondroitin?▼
What is the best stack for joints?▼
References
- Khavinson VKh et al. “Tissue-specific effects of peptides.” Bulletin of Experimental Biology and Medicine (2001). PMID: 11713572
- Khavinson VKh, Lin’kova NS, Tarnovskaya SI “Short peptides regulate gene expression.” Bulletin of Experimental Biology and Medicine (2016). PMID: 27909961
- Khavinson VKh, Morozov VG “Peptides of pineal gland and thymus prolong human life.” Neuroendocrinology Letters (2003). PMID: 14523363
📚 Related Articles
Affiliate links: we earn a commission if you buy, at no extra cost to you.
Cartesyl is Vita-Stream's US-made cartilage bioregulator (Vita Peptides' own house line), a different product from Sigumir. No trial has tested it.
Browse CartesylGet Sigumir from Vita-Stream, which sells the GARMONIA Cytomax and Cytogen oral capsules. No reconstitution math on a capsule bottle.
Browse Sigumir